Charles Schwab
CRNC icon

Charles Schwab’s Cerence CRNC Stock Holding History

Charles Schwab’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
134,053
+12,768
+11% +$125K ﹤0.01% 2875
2026
Q1 		$765K Sell
121,285
-4,135
-3% -$37.3K ﹤0.01% 2978
2025
Q4 		$1.34M Sell
125,420
-25
-0% -$275 ﹤0.01% 2832
2025
Q3 		$1.56M Sell
125,445
-9,562
-7% -$98K ﹤0.01% 2812
2025
Q2 		$1.38M Buy
135,007
+7,033
+5% +$61.9K ﹤0.01% 2788
2025
Q1 		$1.01M Sell
127,974
-50,016
-28% -$615K ﹤0.01% 2837
2024
Q4 		$1.4M Sell
177,990
-45,767
-20% -$230K ﹤0.01% 2794
2024
Q3 		$705K Sell
223,757
-267,940
-54% -$788K ﹤0.01% 3033
2024
Q2 		$1.39M Sell
491,697
-51,647
-10% -$368K ﹤0.01% 2814
2024
Q1 		$8.56M Buy
543,344
+28,043
+5% +$474K ﹤0.01% 2065
2023
Q4 		$10.1M Buy
515,301
+1,054
+0.2% +$18.3K ﹤0.01% 1979
2023
Q3 		$10.5M Sell
514,247
-6,892
-1% -$173K ﹤0.01% 1885
2023
Q2 		$15.2M Buy
521,139
+4,856
+0.9% +$133K ﹤0.01% 1681
2023
Q1 		$14.5M Buy
516,283
+20,748
+4% +$533K ﹤0.01% 1685
2022
Q4 		$9.18M Buy
495,535
+62,900
+15% +$1.08M ﹤0.01% 1909
2022
Q3 		$6.82M Buy
432,635
+56,048
+15% +$1.26M ﹤0.01% 2051
2022
Q2 		$9.5M Buy
376,587
+23,907
+7% +$715K ﹤0.01% 1862
2022
Q1 		$12.7M Buy
352,680
+38,768
+12% +$1.91M ﹤0.01% 1818
2021
Q4 		$24.1M Buy
313,912
+8,964
+3% +$790K 0.01% 1429
2021
Q3 		$29.3M Sell
304,948
-706
-0.2% -$77.1K 0.01% 1247
2021
Q2 		$32.6M Sell
305,654
-3,849
-1% -$379K 0.01% 1186
2021
Q1 		$27.7M Sell
309,503
-8,724
-3% -$960K 0.01% 1254
2020
Q4 		$32M Buy
318,227
+5,494
+2% +$410K 0.01% 1057
2020
Q3 		$15.3M Sell
312,733
-3,563
-1% -$171K 0.01% 1394
2020
Q2 		$12.9M Buy
316,296
+81,243
+35% +$2.33M 0.01% 1472
2020
Q1 		$3.62M Buy
235,053
+16,477
+8% +$346K ﹤0.01% 1997
2019
Q4 		$4.95M Buy
+218,576
New +$3.59M ﹤0.01% 2019

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Charles Schwab's CRNC Position: Q2 2026 in Review

Charles Schwab increased its Cerence (CRNC) stake by 11% in Q2 2026, buying an estimated $125K and bringing the position to 134,053 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2875.

Charles Schwab first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $32.6M in Q2 2021. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Charles Schwab held 134,053 shares of Cerence worth $1.52M as of Q2 2026.
  • Charles Schwab bought 12,768 Cerence shares in Q2 2026, an estimated $125K.
  • Cerence made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2875 holding.
  • Charles Schwab first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • Charles Schwab's Cerence position peaked at $32.6M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.